Albumin-based nanoparticles: a potential and emerging oral drug delivery system.

IF 2.2 4区 医学 Q3 CHEMISTRY, MEDICINAL
Yanping Sun, Huijia Song, Shuo Li, Huimin Zhang, Yongjun Sun, Zibin Gao
{"title":"Albumin-based nanoparticles: a potential and emerging oral drug delivery system.","authors":"Yanping Sun, Huijia Song, Shuo Li, Huimin Zhang, Yongjun Sun, Zibin Gao","doi":"10.1080/03639045.2025.2504440","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The purpose of this review is to elaborate current development and challenges of oral albumin nanoparticles, and realize their clinical application.</p><p><strong>Significance: </strong>Albumin is an emerging protein nanocarrier with a high degree of versatility, safety, stability, modifiability. These characteristics endow albumin nanoparticles with considerable attention and unique roles in drug delivery. However, most albumin nanoparticles are administered intravenously instead of orally, although oral administration is the most popular and common drug delivery route. Oral administration of albumin nanoparticles is their inevitable tendency, but researches referred to this area are still in infancy.</p><p><strong>Methods and results: </strong>Given that, firstly, the basic properties of albumin nanoparticles, like preparation methods, drug loading strategies, targeted drug delivery, and clinical application were simply discussed to provide design guide for their oral administration. Subsequently, the functions and challenges of albumin nanoparticles in oral drug delivery, and strategies to overcome the barriers were highlighted. Finally, aiming to realize their clinical potentials, the possible future trends of orally administrated albumin nanoparticles were also elaborated.</p><p><strong>Conclusions: </strong>In this review, albumin nanoparticles were comprehensively introduced, especially their functions and challenges in oral drug delivery, aiming to guide their design and development.</p>","PeriodicalId":11263,"journal":{"name":"Drug Development and Industrial Pharmacy","volume":" ","pages":"679-690"},"PeriodicalIF":2.2000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Development and Industrial Pharmacy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/03639045.2025.2504440","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/16 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The purpose of this review is to elaborate current development and challenges of oral albumin nanoparticles, and realize their clinical application.

Significance: Albumin is an emerging protein nanocarrier with a high degree of versatility, safety, stability, modifiability. These characteristics endow albumin nanoparticles with considerable attention and unique roles in drug delivery. However, most albumin nanoparticles are administered intravenously instead of orally, although oral administration is the most popular and common drug delivery route. Oral administration of albumin nanoparticles is their inevitable tendency, but researches referred to this area are still in infancy.

Methods and results: Given that, firstly, the basic properties of albumin nanoparticles, like preparation methods, drug loading strategies, targeted drug delivery, and clinical application were simply discussed to provide design guide for their oral administration. Subsequently, the functions and challenges of albumin nanoparticles in oral drug delivery, and strategies to overcome the barriers were highlighted. Finally, aiming to realize their clinical potentials, the possible future trends of orally administrated albumin nanoparticles were also elaborated.

Conclusions: In this review, albumin nanoparticles were comprehensively introduced, especially their functions and challenges in oral drug delivery, aiming to guide their design and development.

基于白蛋白的纳米颗粒:一种潜在的和新兴的口服给药系统。
目的:综述口服白蛋白纳米颗粒的研究现状和面临的挑战,并实现其临床应用。意义:白蛋白是一种新兴的蛋白质纳米载体,具有高度的通用性、安全性、稳定性和可修饰性。这些特性赋予了白蛋白纳米颗粒相当大的关注和独特的作用,在药物传递。然而,大多数白蛋白纳米颗粒是静脉注射而不是口服给药,尽管口服给药是最流行和最常见的给药途径。口服白蛋白纳米颗粒是其发展的必然趋势,但这方面的研究还处于起步阶段。方法与结果:本文首先对白蛋白纳米颗粒的制备方法、载药策略、靶向给药、临床应用等基本特性进行了简单的探讨,为其口服给药提供设计指导。随后,重点介绍了白蛋白纳米颗粒在口服给药中的作用和挑战,以及克服这些障碍的策略。最后,针对其临床应用潜力,阐述了口服白蛋白纳米颗粒的未来发展趋势。结论:本文全面介绍了白蛋白纳米颗粒的功能及其在口服给药方面面临的挑战,旨在指导其设计和开发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.80
自引率
0.00%
发文量
82
审稿时长
4.5 months
期刊介绍: The aim of Drug Development and Industrial Pharmacy is to publish novel, original, peer-reviewed research manuscripts within relevant topics and research methods related to pharmaceutical research and development, and industrial pharmacy. Research papers must be hypothesis driven and emphasize innovative breakthrough topics in pharmaceutics and drug delivery. The journal will also consider timely critical review papers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信